- Home
- EWCZ vs ABSI Comparison
EWCZ vs ABSI Comparison
Compare EWCZ & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWCZ
- ABSI
- Stock Information
- Founded
- EWCZ 2004
- ABSI 2011
- Country
- EWCZ United States
- ABSI United States
- Employees
- EWCZ N/A
- ABSI N/A
- Industry
- EWCZ Package Goods/Cosmetics
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- EWCZ Consumer Discretionary
- ABSI Health Care
- Exchange
- EWCZ Nasdaq
- ABSI Nasdaq
- Market Cap
- EWCZ 146.9M
- ABSI 353.8M
- IPO Year
- EWCZ 2021
- ABSI 2021
- Fundamental
- Price
- EWCZ $3.60
- ABSI $2.80
- Analyst Decision
- EWCZ Buy
- ABSI Strong Buy
- Analyst Count
- EWCZ 7
- ABSI 5
- Target Price
- EWCZ $5.64
- ABSI $8.40
- AVG Volume (30 Days)
- EWCZ 753.6K
- ABSI 2.5M
- Earning Date
- EWCZ 05-14-2025
- ABSI 05-13-2025
- Dividend Yield
- EWCZ N/A
- ABSI N/A
- EPS Growth
- EWCZ 29.60
- ABSI N/A
- EPS
- EWCZ 0.22
- ABSI N/A
- Revenue
- EWCZ $216,916,000.00
- ABSI $4,534,000.00
- Revenue This Year
- EWCZ N/A
- ABSI $158.58
- Revenue Next Year
- EWCZ $2.69
- ABSI $93.12
- P/E Ratio
- EWCZ $16.23
- ABSI N/A
- Revenue Growth
- EWCZ N/A
- ABSI N/A
- 52 Week Low
- EWCZ $2.72
- ABSI $2.01
- 52 Week High
- EWCZ $12.05
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- EWCZ 51.78
- ABSI 44.49
- Support Level
- EWCZ $3.12
- ABSI $2.85
- Resistance Level
- EWCZ $3.42
- ABSI $3.16
- Average True Range (ATR)
- EWCZ 0.21
- ABSI 0.20
- MACD
- EWCZ 0.10
- ABSI -0.03
- Stochastic Oscillator
- EWCZ 98.48
- ABSI 19.57
About EWCZ European Wax Center Inc.
European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax. Its services include Brazilian Waxing, Brow Waxing, Body Waxing, Facial Waxing, All Waxing Services, Eyebrow Tinting, Laser Hair Removal, Men's Waxing Services and others.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.